准KIF20A:癌症治疗的新前沿,由多omics分析揭示
Jie Zhang1, Guanghao Li1, Chunling Qi2
1Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Jinan, China.
Frontiers in immunology
|February 6, 2026
概括
素家族成员20A (KIF20A) 是许多癌症中瘤生长的关键驱动因素. 这项研究揭示了其泛癌作用,将KIF20A与不良预后联系起来,并将其确定为癌症治疗的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 素家族成员20A (KIF20A) 是一种运动蛋白质,参与细胞分裂和器官运输.
- 它的失调表达与癌症转移和患者预后有关,但其泛癌功能仍然不清楚.
研究的目的:
- 系统地分析KIF20A在各种癌症中的多基因变异.
- 评估KIF20A在瘤微环境中的作用及其作为抗癌治疗点的潜力.
主要方法:
- 来自癌症数据库的综合多学科数据.
- 分析了KIF20A基因表达,基因组变异,甲基化和通路关联.
- 利用生物信息算法用于瘤微环境和免疫治疗分析.
- 在脏,脏清细胞癌 (KIRC) 细胞上进行了体外和体内实验.
主要成果:
- KIF20A作为瘤细胞增殖中的核心基因,与多种癌症的临床进展和不良预后有关.
- 异常的表观遗传修饰和突变有助于KIF20A失调.
- KIF20A的表达与免疫细胞透相关,并影响免疫疗法的疗效.
- 抑制KIF20A抑制了KIRC细胞的增殖,迁移和入侵,并在体内减少了瘤生长.
结论:
- 这是第一个泛癌症,多组学研究,阐明了KIF20A在瘤发生中的作用.
- 提供了强有力的证据支持KIF20A作为各种癌症的潜在治疗点.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Cancer Survival Analysis
769
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
769
Multi-input and Multi-variable systems
426
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence of...
In the absence of...
426
Multi-Step Reactions
8.8K
Chemical reactions often occur in a stepwise fashion involving two or more distinct reactions taking place in a sequence. A balanced equation indicates the reacting species and the product species, but it reveals no details about how the reaction occurs at the molecular level. The reaction mechanism (or reaction path) provides details regarding the precise, step-by-step process by which a reaction occurs. Each of the steps in a reaction mechanism is called an elementary reaction. These...
8.8K
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K


